"This drug and this oral dose should have been removed from the market a long time ago," Jennifer Schwartzott, a patient representative from New York, told NBC News
Lund and coworkers sequenced the anglerfish proglucagon peptide in 1982 [5]
Within a day, the FDA issued a statement that went past general caution and into explicit enforcement intent: it said it plans decisive steps to restrict GLP-1 APIs intended for non-FDA-approved compounded drugs that are being mass-marketed as similar alternatives, specifically including Hims & Hers
Technically speaking, you can use nearly any needle you like
Im glad we did it
That single interaction has downstream effects across several healing pathways: it supports stem-cell migration to injury sites, promotes angiogenesis (like BPC-157, but through a different mechanism), and dampens inflammatory signaling during the repair phase